Latest Content

The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.

Dr. Sheldon M. Feldman says patients with breast cancer should accept support and make exercise and wellness priorities during treatment to improve outcomes.

CURE spoke with Alyson B. Moadel-Robblee of Montefiore Einstein Center for Cancer Care.

Twanda Frazier guides patients with cancer through Reiki, helping them release stress and find calm, while survivor Radha Narayan shares her positive experience.

CURE spoke with experts about possible side effects faced by patients with breast cancer.

I share how my dog helped me through treatment during the pandemic and how adopting a new one reminds me to keep living and planning for a future beyond cancer.

Dr Anjana Pillai explains screening, imaging and biopsy for liver cancer, why staging matters and which questions help patients understand care.

After a surprise diagnosis at 47, salon owner Christa Messmer found strength, faith and renewed meaning in life while facing colorectal cancer.

Eleven years after surviving breast cancer, I found a new lump that reignited old fears, reminding me that faith and vigilance remain vital to survivorship.

CURE spoke with Alexa M. Lantz of Penn State Health about radiation side effects.

Alecensa cut the risk of death by 22% versus Xalkori, with median overall survival reaching 81.1 months versus 54.2 months in advanced ALK-positive lung cancer.

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

Reiki master Twanda Frazier says reiki helps patients with cancer release what no longer serves them and restore emotional and spiritual balance.